The inheritance of resistance alleles in multiple sclerosis

PLoS Genetics

Volumn 3, Issue 9, 2007, Pages 1607-1613

  Ramagopalan, Sreeram V ^a,b   Morris, Andrew P ^a   Dyment, David A ^a,b   Herrera, Blanca M ^a,b   DeLuca, Gabriele C ^a,b   Lincoln, Matthew R ^a,b   Orton, Sarah M ^a,b   Chao, Michael J ^a,b   Sadovnick, A Dessa ^c   Ebers, George C ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQB1 ANTIGEN; HLA DR ANTIGEN; HLA DR1 10 ANTIGEN; HLA DRB1 01 ANTIGEN; HLA DRB1 11 ANTIGEN; HLA DRB1 14 ANTIGEN; UNCLASSIFIED DRUG;

ALLELE; ANTIGEN PRESENTATION; ARTICLE; GENE LOCUS; GENETIC RESISTANCE; GENETIC RISK; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNE RESPONSE; INHERITANCE; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; RISK ASSESSMENT; RISK REDUCTION; VALIDATION PROCESS;

ALLELES; GENOTYPE; HAPLOTYPES; HLA ANTIGENS; HUMANS; LINKAGE DISEQUILIBRIUM; MULTIPLE SCLEROSIS;

ANIMALIA;

EID: 34848917282     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.0030150     Document Type: Article

References (31)

1. Sadovnick AD, Baird PA, Ward RH (1988) Multiple sclerosis: Updated risks for relatives. Am J Med Genet 29: 533-541.
2. Ebers GC, Sadovnick AD, Risch NJ (1995) A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group. Nature 377: 150-151.
3. Willer CJ, Dyment DA, Risch NJ, Sadovnick AD, Ebers GC (2003) Twin concordance and sibling recurrence rates in multiple sclerosis. Proc Natl Acad Sci U S A 100: 12877-12882.
4. Dyment DA, Sadovnick AD, Willer CJ, Armstrong H, Cader ZM, et al. (2004) An extended genome scan in 442 Canadian multiple sclerosis-affected sibships: A report from the Canadian Collaborative Study Group. Hum Mol Genet 13: 1005-1015.
5. Jersild C, Svejgaard A, Fog T (1972) HL-A antigens and multiple sclerosis. Lancet 1: 1240-1241.
6. Naito S, Namerow N, Mickey MR, Terasaki PI (1972) Multiple sclerosis: Association with HL-A3. Tissue Antigens 2: 1-4.
7. Winchester R, Ebers G, Fu SM, Espinosa L, Zabriskie J, et al. (1975) B-cell alloantigen Ag 7a in multiple sclerosis. Lancet 2: 814.
8. Fogdell A, Hillert J, Sachs C, Olerup O (1995) The multiple sclerosis- and narcolepsy-associated HLA class II haplotype includes the DRB5*0101 allele. Tissue Antigens 46: 333-336.
9. Dyment DA, Ebers GC, Sadovnick AD (2004) Genetics of multiple sclerosis. Lancet Neurology 3: 104-110.
10. Dyment DA, Herrera BM, Cader MZ, Willer CJ, Lincoln MR, et al. (2005) Complex interactions among MHC haplotypes in multiple sclerosis: Susceptibility and resistance. Hum Mol Genet 14: 2019-2026.
11. Marrosu MG, Murru MR, Costa G, Cucca F, Sotgiu S, et al. (1997) Multiple sclerosis in Sardinia is associated and in linkage disequilibrium with HLA-DR3 and -DR4 alleles. American Journal of Human Genetics 61: 454-457.
12. Modin H, Olsson W, Hillert J, Masterman T (2004) Modes of action of HLA-DR susceptibility specificities in multiple sclerosis. Am J Hum Genet 74: 1321-1322.
13. Barcellos LF, Sawcer S, Ramsay PP, Baranzini SE, Thomson G, et al. (2006) Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet 15: 2813-2824.
14. Ebers GC, Kukay K, Bulman DE, Sadovnick AD, Rice G, et al. (1996) A full genome search in multiple sclerosis. Nat Genet 13: 472-476.
15. Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallstrom E, et al. (2007) Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet. E-pub 29 July 2007.
16. Lincoln MR, Montpetit A, Cader MZ, Saarela J, Dyment DA, et al. (2005) A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet 37: 1108-1112.
17. Middleton D, Menchaca L, Rood H, Komerofsky R (2003) New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens 61: 403-407.
18. Barcellos LF, Oksenberg JR, Begovich AB, Martin ER, Schmidt S, et al. (2003) HLA-DR2 dose effect on susceptibility to multiple sclerosis and influence on disease course. American Journal of Human Genetics 72: 710-716.
19. Boon M, Nolte IM, De Keyser J, Buys CH, te Meerman GJ (2004) Inheritance mode of multiple sclerosis: The effect of HLA class II alleles is stronger than additive. Hum Genet 115: 280-284.
20. Rasmussen HB, Kelly MA, Clausen J (2001) Additive effect of the HLA-DR15 haplotype on susceptibility to multiple sclerosis. Mult Scler 7: 91-93.
21. Ebers GC, Paty DW (1980) Studies in familial multiple sclerosis. Trans Am Neurol Assoc 105: 344-347.
22. Chao MJ, Barnardo MC, Bu GZ, Lincoln MR, Ramagopalan SV, et al. (2007) Transmission of class I/II multi-locus MHC haplotypes and multiple sclerosis susceptibility: accounting for linkage disequilibrium. Hum Mol Genet.
23. Andersson G (1998) Evolution of the human HLA-DR region. Front Biosci 3: D739-D745.
24. Sasazuki T, Kaneoka H, Nishimura Y, Kaneoka R, Hayama M, et al. (1980) An HLA-linked immune suppression gene in man. J Exp Med 152: 297S-313S.
25. Nishimura Y, Sasazuki T (1983) Suppressor T cells control the HLA-linked low responsiveness to streptococcal antigen in man. Nature 302: 67-69.
26. Gregersen JW, Kranc KR, Ke X, Svendsen P, Madsen LS, et al. (2006) Functional epistasis on a common MHC haplotype associated with multiple sclerosis. Nature.
27. Sadovnick AD, Risch NJ, Ebers GC (1998) Canadian collaborative project on genetic susceptibility to MS, phase 2: Rationale and method. Canadian Collaborative Study Group. Can J Neurol Sci 25: 216-221.
28. Olerup O, Zetterquist H (1992) HLA-DR typing by PCR amplification with sequence-specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens 39: 225-235.
29. Cordell HJ, Clayton DG (2002) A unified stepwise regression procedure for evaluating the relative effects of polymorphisms within a gene using case/control or family data: Application to HLA in type 1 diabetes. Am J Hum Genet 70: 124-141.
30. Cordell HJ (2004) Properties of case/pseudocontrol analysis for genetic association studies: Effects of recombination, ascertainment, and multiple affected offspring. Genet Epidemiol 26: 186-205.
31. The International Multiple Sclerosis Genetics Consortium (2007) Risk alleles for multiple sclerosis identified by a genomewide study. N Engl J Med. E-pub ahead of print. 29 July 2007.